Day: July 17, 2020

SpareBank 1 SMN inviterer til presentasjon av resultatene for 2. kvartal 2020.Tid:        Tirsdag, 11. august, kl. 13.30Sted:     WebinarPåmelding innen 9. august via følgende link:http://epost.sparebank1.no/public/event/RegistrationForm/42455B407243475A427140Presentasjonene holdes av konsernsjef Jan-Frode Janson og finansdirektør Kjell Fordal.Det vil også bli holdt et webinar på engelsk samme dag klokken 15:30.Påmelding innen 9. august her:http://epost.sparebank1.no/public/event/RegistrationForm/42455B4075454A584A7440Spørsmål til begge presentasjoner kan sendes til investorrelations@smn.no. Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

$400M Debt Facility Provides Path to Profitability Without the Need for Any Future Dilutive Financings Self-sustainable Financial Profile Achieved with Comprehensive, Low Cost Debt Structure and Includes Retiring Prior Term LoanCompany Reiterates 2020 Galafold Revenue of $250-$260M and 2020 Operating Expense GuidanceCRANBURY, N.J., July 17, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that it has executed a definitive agreement for a $400 million credit facility with Hayfin Capital Management (“Hayfin”). The strategic financing allows Amicus to deliver on its mission for patients and shareholders and places it firmly on a path to profitability and its vision to become...

EDMONTON, Alberta, July 17, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a manufacturer of high quality cannabinoid-based formulations and products, is pleased to announce that bioU products by Radient will be available to patients in the recently announced University Health Networks’ (“UHN”)  Medical Cannabis Real-World Evidence Study (“MC-RWE Study”) in partnership with Medical Cannabis by Shoppers.  The first-of-its-kind study will involve a nation-wide clinical trial to examine the effects of medical cannabis on pain, sleep and anxiety issues.Radient developed the bioU brand exclusively for Medical Cannabis by Shoppers and the products have been formulated to meet the highest levels of quality, consistency, and stability.  All three oral spray formulations currently...

MONTREAL, July 17, 2020 (GLOBE NEWSWIRE) — Le Château Inc. (the “Company”) (TSX VENTURE: CTU) today provided an update on the status of the filing of its interim financial statements and management’s discussion and analysis, and related CEO and CFO certificates, for its first quarter ended April 25, 2020 (the “Q1 Documents”).On May 20, 2020, the Canadian securities administrators (“CSA”) announced that they would provide issuers with a 45-day filing extension for filings due or required to be made during the period from June 2, 2020 to August 31, 2020 to allow issuers the time needed to focus on the many other business and financial reporting implications of the COVID-19 pandemic.As previously announced on June 19, 2020, the Company is relying on the 45‑day blanket extension granted by the CSA for the filing of the Q1 Documents....

MONTRÉAL, 17 juill. 2020 (GLOBE NEWSWIRE) — Le Château Inc. (la « Société ») (TSXV : CTU) a fait le point aujourd’hui sur le dépôt de ses états financiers intermédiaires et de son rapport de gestion, ainsi que des attestations de la chef de la direction et de la chef des finances afférentes à ces documents, pour son premier trimestre clos le 25 avril 2020 (les « documents du T1 »).Le 20 mai 2020, les Autorités canadiennes en valeurs mobilières (« ACVM ») ont annoncé qu’elles accorderaient aux émetteurs une prolongation de 45 jours pour effectuer les dépôts requis pour la période du 2 juin 2020 au 31 août 2020 afin de leur donner le temps de se concentrer sur les nombreuses autres conséquences de la pandémie de COVID-19 sur les activités et la présentation de l’information financière.Comme il a été annoncé précédemment le 19 juin 2020,...

SANTA CRUZ, Calif. and TORONTO, July 17, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality for eCommerce, AR learning applications, and AR-enhanced video conferencing and virtual events is pleased to announce that it has launched a new immersive video conferencing software called ScreenAR. The new capabilities are seamlessly integrated into its InfernoAR platform using its ARitize app. The new AR features will allow for AR experiences to “pop” off the computer screen creating a one-of-a-kind immersive experience that everyone is craving today. This new capability is aiming to keep people engaged in virtual classrooms, virtual events, or virtual trade shows, becoming the video conferencing industry standard.SEE DEMO VIDEO HEREThe ScreenAR will work...

The companies signed investment and reseller agreements for joint commercializationOMER, Israel, July 17, 2020 (GLOBE NEWSWIRE) —  Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced the signing of an investment agreement and a reseller agreement with Polyrizon Ltd., a private company engaged in developing biological gels for the purpose of protecting patients against biological threats.As part of the reseller agreement Medigus receives an exclusive global license to resell the Polyrizon products, focusing on a unique Biogel for the protection from COVID-19 virus. The term of the license will be for four years, commencing upon receipt of sufficient FDA approvals for the lawful marketing and sale of the products globally....

• Data being presented at the American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting • Significant improvements demonstrated after treatment in Phase 1/2 clinical trial • Based on encouraging safety and efficacy profile, MeiraGTx and Janssen expect to progress AAV-RPGR into Phase 3 Lumeos clinical trial  • MeiraGTx to host investor conference call on Friday, July 17 at 8:00 a.m. ET     LONDON and NEW YORK, July 17, 2020 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced six-month data from the ongoing Phase 1/2 clinical trial (NCT03252847) of AAV-RPGR, an investigational gene therapy in development for the treatment of patients with X-linked retinitis pigmentosa (XLRP) with genetically confirmed variants in the RPGR gene. Significant...

Company Announcement17 July 2020Announcement No. 20NKT awarded turnkey order for the on- and offshore project Shetland HVDC LinkNKT has been awarded a contract of approx. EUR 235m (approx. DKK 1.75bn) by SSEN Transmission to deliver and install a high-voltage DC (direct current) interconnector to the Shetland HVDC Link project. The turnkey order comprises the manufacturing of approx. 2×260 km of 320 kV high-voltage DC on-and offshore power cables, installation by the cable-laying vessel NKT Victoria and protection of the cables.NKT President and CEO Alexander Kara says:– This turnkey order confirms NKT’s strong position in the market for high-voltage DC interconnectors. I am very pleased that we are selected as partner for the Shetland HVDC Link, which will provide a sustainable grid connection to Shetland and renewable energy...

Selskabsmeddelelse17. juli 2020Meddelelse nr. 20NKT er tildelt turnkey ordre til on- og offshore projektet Shetland HVDC LinkNKT er blevet tildelt en kontrakt til en værdi af cirka EUR 235 mio. (cirka DKK 1,75 mia.) af SSEN Transmission på levering og installation af en højspændings-kabelforbindelse til jævnstrøm (DC) til Shetland HVDC Link-projektet. Turnkey-ordren omfatter produktion af cirka 2×260 km 320 kV DC on- og offshorekabler, installation med kabeludlægningsskibet NKT Victoria samt beskyttelse af kablerne.NKT CEO Alexander Kara siger:– Denne turnkey-ordre bekræfter NKTs stærke position i markedet for interconnectors baseret på jævnstrøms-højspænding. Jeg er meget tilfreds med at NKT er valgt som partner til Shetland HVDC Link, som betyder at Shetland får en bæredygtig tilslutning til elnettet og at der leveres vedvarende...